A venture fund dedicated to accelerating innovations in blood and cellular therapies, and related technologies
NYBC Ventures is focused on a humanitarian & fiscal ROI, fostering New York Blood Center's mission-oriented innovation.
AREAS OF FOCUS
We invest in therapeutics, devices and innovative technologies addressing the most pressing challenges in our areas of focus.
KEY INVESTMENT STRATEGIES
Working with NYBC Ventures goes beyond capital. We provide access to world-renowned researchers and their labs, cell manufacturing capacity, and source materials.
Early-stage companies pursuing advancements in blood-related and cellular therapeutics & technologies
Companies that would benefit from a partnership with Lindsley F. Kimball Research Institute (LFKRI) researchers and cell manufacturing and sourcing capabilities
Discoveries emerging from New York Blood Center research labs